Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

STEMIN- and YAP5SA-induced exosomes prevent cardiomyocyte apoptosis.

iScience·2026
Same author

Distinct populations of vascular smooth muscle and sinoatrial progenitors are localized adjacent to pro-epicardium.

Cell reports·2025
Same author

Tunneling nanotube-like structures regulate distant cellular interactions during heart formation.

Science (New York, N.Y.)·2025
Same author

STEMIN and YAP5SA, the future of heart repair?

Experimental biology and medicine (Maywood, N.J.)·2024
Same author

β1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation.

Cardiovascular research·2024
Same author

A Small Molecule That In Vitro Neutralizes Infection of SARS-CoV-2 and Its Most Infectious Variants, Delta, and Omicron.

Biomedicines·2023

関連する実験動画

Updated: Jul 11, 2026

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
08:13

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart

Published on: September 13, 2011

CAMTAは,心筋縮症において

Robert J Schwartz1, Michael D Schneider

  • 1The Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, Houston, TX 77030, USA. rschwartz@ibt.tamhsc.edu

Cell
|May 9, 2006
PubMed
まとめ

カルモジュリン結合転写活性化剤2 (CAMTA2) は,心筋縮に不可欠である. この状態に関与する遺伝子を活性化させ,ヒストン脱酸化酵素5.5から解離した後,Nkx2-5と相互作用します.

科学分野:

  • 分子生物学は分子生物学である.
  • 心血管研究に関する研究.
  • 遺伝子調節 遺伝子調節

背景:

  • 心筋縮症は,重要な心血管疾患である.
  • 心筋縮を誘発する分子メカニズムを理解することは,効果的な治療法の開発に不可欠です.

研究 の 目的:

  • カルモジュリン結合転写活性化剤2 (CAMTA2) が心筋縮における役割を調査する.
  • CAMTA2が心筋縮に関連する遺伝子を調節するメカニズムを解明する.

主な方法:

  • この研究では,CAMTA2の機能を評価するために分子および遺伝的技術を使用しました.
  • CAMTA2,ヒストン脱酸化酵素5とNkx2-5.5の相互作用を調査しました.

主要な成果:

  • CAMTA2は,心筋縮のための不可欠な転写コアクティベーターとして特定されました.
  • CAMTA2の活性化には,IIクラスヒストン脱酸化酵素の解離が含まれる 5.
  • CAMTA2は,Nkx2-5の相互作用を通じて,心筋縮に関連する遺伝子の転写を促進する.

結論:

  • CAMTA2は,心筋縮の発達に重要な役割を果たしています.

さらに関連する動画

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

関連する実験動画

Last Updated: Jul 11, 2026

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
08:13

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart

Published on: September 13, 2011

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

  • CAMTA2経路を標的にすることは,心筋縮の治療戦略を提供することができる.